In patients with poor blood pressure control despite treatment with a combination of three drugs ('resistant hypertension'), addition of the diuretic spironolactone was significantly more effective than adding other blood ...
When it comes to treating high blood pressure, not all anti-hypertensive medications are equal, and results of the ATTEMPT-CVD trial suggest that telmisartan, an angiotensin II receptor blocker (ARB) might have benefits over ...
In patients with type 2 diabetes and acute coronary syndrome, the glucose-lowering medication lixisenatide did not increase or decrease the rate of cardiovascular (CV) events compared to placebo, according to results of the ...
Patients with type-2 diabetes and cardiovascular disease can safely take the antihyperglycemic drug sitagliptin without an increased risk of cardiovascular complications - even if they have a history of heart failure - a ...
In older patients with arthritis and no history of cardiovascular disease, chronic use of any non-steroidal anti-inflammatory drug appears safe from a cardiovascular and gastrointestinal stand-point, and regular, non-selective ...
In heart failure patients with diabetes and/or chronic kidney disease, a new, non-steroidal mineralocorticoid receptor antagonist (MRA) called finerenone was no more effective than the currently approved MRA eplerenone in ...
An innovative radiotherapy technique that has the potential to revolutionise the treatment of early breast cancer will become available and affordable for all eligible women under Medicare from tomorrow.
We started August with World Breastfeeding Week and a post on how women aren't getting the support they need to meet their own breastfeeding goals. August ends with another important theme: Black Breastfeeding Week.